Markets

  • Rendever secures nearly US$4.5m to fight isolation

    Virtual reality firm Rendever has secured nearly US$4.5m in grants to tackle social isolation among older adults through immersive technology. The funding from the National Institutes of Health (NIH) includes US$3.8m for the Thrive At Home Program and an additional grant to build a caregiver support network in VR. These funds will enable Rendever to [...]

  • CareScout completes Seniorly acquisition

    CareScout has completed its purchase of Seniorly, with the adviser network and partners to migrate to the CareScout platform in the coming months. CareScout said the deal strengthens its direct-to-consumer capabilities and accelerates plans to help families understand, find and pay for long-term care — ongoing support with daily activities such as bathing, dressing and [...]

  • Round up: US$25m fund to reimagine human longevity

    Age Tech World explores the latest business developments in the world of age technology and longevity US$25m fund to reimagine human longevity India-based entrepreneur Deepinder Goyal has announced the launch of Continue Research, supported by a US$25m personal fund dedicated to advancing global longevity science. Continue Research was founded two years ago as an independent [...]

  • AlayaCare buys Nightingale to expand ANZ aged care

    AlayaCare has acquired Nightingale Software to expand its aged care footprint in Australia and New Zealand, pending customary conditions and regulatory approvals. AlayaCare Nightingale’s platform will continue to operate and staff will be retained, with services supported by AlayaCare’s technology, product roadmap and resources. The company says its all-in-one platform offers real-time data insights, personalised [...]

  • Canada approves Leqembi for early Alzheimer’s

    Canada has conditionally approved Leqembi (lecanemab), the first treatment that targets an underlying cause of early Alzheimer’s disease by removing toxic amyloid beta proteins from the brain. Health Canada issued the Notice of Compliance with Conditions on 27 October for adults with mild cognitive impairment or mild dementia due to Alzheimer’s disease who have confirmed [...]

  • Weight loss drug reduces heart attack and stroke risk regardless of weight loss

    Semaglutide reduces the risk of heart attack and stroke by 20 per cent, regardless of weight lost, according to the largest study of 17,604 patients. The drug, the main ingredient in Wegovy, reduced the risk of major adverse cardiac events — including deaths from heart disease, heart attacks or strokes — by 20 per cent, [...]

  • Hesperos wins grant to tackle drug-induced dementia

    Hesperos has been awarded a NIA Phase IIB SBIR grant to study how combinations of medicines raise the risk of drug-induced dementia in older adults. In partnership with GalenusRx, the company will use its Human-on-a-Chip (HoaC) multi-organ systems to examine how certain medicines interact and may drive cognitive decline. The technology uses miniature organ systems [...]

  • Most Americans would be considered obese under new guidelines

    Almost 70 per cent of US adults would be classified as having obesity under a new definition proposed by medical experts — a major increase from 43 per cent using current BMI standards. The proposed obesity definition expands beyond body mass index (BMI) to include waist measurements and body fat scans, identifying many more people [...]

  • Cairns buys AI health app Together by Renee

    Cairns Health has acquired AI app Together by Renee and will fold its medication tech into Luna to support older adults and people with chronic conditions. Together by Renee uses computer vision (software that reads images) to scan pill labels for reminders and refills, and “agentic” AI (systems that act toward a goal) to automate [...]

  • Roundup: Atlas maps molecular fingerprints of health, disease and ageing

    Age Tech World explores the latest research developments in the world of ageing and longevity. Pan-disease atlas maps molecular fingerprints of health, disease and ageing A new study has mapped the distinct molecular “fingerprints” that 59 diseases leave in an individual’s blood protein, which would enable blood tests to discern troubling signs from those that [...]